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Objectives: Obesity in childhood increases the risk of obesity in adulthood, and is
predictive of the development of metabolic disorders. The fatty acid composi-
tions of various tissues, including blood, are associated with obesity and obesity-
associated disorders. Thus, tracking plasma phospholipid (PL) features and
metabolic parameters in young individuals may strengthen the utility of fatty
acid composition as an early biomarker of future metabolic disorders.
Methods: Anthropometric and blood biochemical data were obtained from 131
Korean males aged 10.5  0.4 years, and followed up at 2 years. We analyzed the
plasma PL fatty acids according to obesity. Obese children were defined as those
with a body mass index (BMI) greater than the 85th percentile for age and gender,
based on Korean child growth standards.
Results: Activities of lipid desaturases, stearyl-CoAD (SCD-16,16:1n-7/16:0),
delta-6D (D6D, 20:3n-6/18:2n-6), and delta-5D (D5D, 20:4n-6/20:3n-6), were
estimated. Obese individuals had significantly higher proportions of palmitoleic
acid (16:1n-7) and dihomo-gamma linolenic acid (DGLA, 20:3n-6) at both baseline
and follow-up than did lean individuals. The activities of SCD-16 and D6D were
higher in obese than lean boys. The baseline SCD-16 activity level was positively
associated with the baseline waist circumference (WC) and the metabolic risk
score. The baseline D6D level was positively associated with WC and also with theted under the terms of the Creative Commons Attribution Non-Commercial License (http://
0) which permits unrestricted non-commercial use, distribution, and reproduction in any
roperly cited.
ticle.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
252 Y.S. Choi, et alhomeostasis model of assessment of insulin resistance (HOMA-IR), a surrogate
marker of insulin resistance (IR), and metabolic risk score at both baseline and
follow-up.
Conclusion: In young Korean males, higher D6D activity predicts the future
development of IR and associated metabolic disorders including dyslipidemia.1. Introduction
Obesity has become increasingly prevalent among
children and adolescents in many countries. Childhood
obesity increases the risk of developing health problems
including insulin resistance (IR) and metabolic syndrome
[1,2], and also adult obesity and cardiovascular disease
[3,4]. Therefore, early detection of childhood obesity and
metabolic disorders is required to efficiently prevent
development of problems in adulthood. Studies on child
populations may clarify the mechanisms underlying the
development of obesity and metabolic disorders, because
problems in children are not confounded by the conse-
quences of advanced metabolic disorders.
The levels of specific serum fatty acids and fatty acid
desaturases have been suggested to serve as useful
biomarkers predicting the development of IR and
metabolic disorders [5e11]. Higher levels of saturated
fatty acids, palmitoleic acid, linoleic acid, and dihomo-
gamma linolenic acid (DGLA), have been reported to be
associated with obesity and metabolic syndrome. In
addition, both animal and human studies have suggested
that fatty acid desaturases play roles in various meta-
bolic disturbances, including dyslipidemia and IR [12].
The data have been derived principally from cross-
sectional studies, which cannot predict the future
development of obesity and metabolic disorders. Lon-
gitudinal studies can yield integrated information on the
development of metabolic disorders over time, and can
identify the optimal points of intervention [13]. There-
fore, in the present study, we explored the longitudinal
relations of plasma phospholipid (PL) fatty acid
composition and desaturase activities to IR and meta-
bolic risk factors in Korean boys.2. Materials and methods
2.1. Study participants and anthropometric
parameters
This study is part of the Korean Children and
Adolescent Cohort Study, which follows a student
cohort from the time of entry into elementary school (at
7 years of age) to graduation (at age 19 years) in Seoul
and Kyunggi provinces, Korea. The overall objective of
the cohort study is to identify early risk factors for
obesity and associated metabolic disease. The study was
approved by the Institutional Review Board of the Korea
Center for Disease Control and Prevention and theEthics Committee of Seoul-Paik Hospital, Inje Univer-
sity, Seoul, Korea. Informed parental consent was ob-
tained for each individual prior to enrolment. Body
weight and body fat percentage were measured using a
body composition analyzer (BC418; Tanita, Tokyo,
Japan) and height was measured using an automatic
stadiometer (DS-102; Jenix, Seoul, Korea). Obese chil-
dren were defined as those with a body mass index
(BMI) greater than the 85th percentile for age and
gender, based on Korean child growth standards [14]. A
total of 131 boys aged 9e11 years in 2008e2009 were
included. After 2 years, health data were obtained once
more.
2.2. Biochemical analysis
Each blood sample was collected from an antecubital
vein into a vacutainer tube between 9:00 AM and
11:00 AM after a 12-hour overnight fast. Within 30 mi-
nutes, plasma and serum were separated and stored at
80C prior to further analysis. The levels of triglyc-
eride (TG), total cholesterol, high-density lipoprotein-
cholesterol (HDL-C), alanine aminotransferase (ALT),
aspartate aminotransferase (AST), and glucose were
measured using an autoanalyzer (model 7600II; Hitachi,
Tokyo, Japan). The fasting serum insulin level was
measured using a Roche E170 instrument (Roche Di-
agnostics, Mannheim, Germany). The IR index was
calculated using the homeostasis model assessment of
insulin resistance (HOMA-IR) [15]. A metabolic risk
score was constructed by summing the z-score of five
metabolic risk factors, which are BMI, systolic blood
pressure (SBP), TG, HDL-C, and HOMA-IR [16].
2.3. Fatty acid analysis
Plasma lipids were extracted using a modification of
the method of Folch et al [17]. The PL fraction was iso-
lated by thin-layer chromatography and the fatty acids
were converted into methyl esters using the method of
Lepage and Roy [18]. The composition of the methylated
fatty acid mix was determined by gas chromatography
(HP 7890A; Hewlett-Packard, Palo Alto, CA, USA). In-
dividual fatty acids were identified by comparing reten-
tion times to those of standards and quantified based on
the peak area relative to the total methylated fatty acid
peak area (set at 100%). Desaturase levels were estimated
by calculating the product:precursor ratios of individual
fatty acids (using the proportions calculated above) as
follows: delta-6D (D6D)Z [20:3n-6/18:2n-6]; delta-6D
(D5D) Z [20:4n-6/20:3n-6]; stearyl-CoAD-16 (SCD-
Desaturase Activity and Insulin Resistance in Boys 25316) Z [16:1n-7/16:0]; and stearyl-CoAD-18 (SCD-
18)Z [18:1n-9/18:0] [18].
2.4. Statistical analysis
Statistical analyses were performed with the aid of
SAS software (version 9.1; SAS Institute, Cary, NC,
USA). All data are expressed as mean  standard de-
viation (SD). The normality of data distribution was
checked. Variables with skewed distributions were log-
transformed prior to analysis. The significance of
observed between-group differences was assessed using
the unpaired Student t test and the significance of
among-group differences was analyzed using one-way
analysis of variance (ANOVA). If a statistically signif-
icant effect was noted, Duncan’s post-hoc test was
applied to identify a between-group difference with a
significance level of p < 0.05. Pearson correlation co-
efficients were calculated to measure the extent of cor-
relation between pairs of variables.3. Results
3.1. Participant characteristics
Anthropometric and biological characteristics of all
individuals at baseline are shown in Table 1. At
commencement of the study, 75 of 131 boys were obese,Table 1. Anthropometric and biochemical characteristics of the
Baseline
Lean (n Z 56) Obese (n Z 75) p0
a
Age (y) 10.5  0.6*** 10.4  0.6yyy 0.161
Height (cm) 142.7  5.3*** 144.6  6.6yyy 0.073
Body weight (kg) 37.1  3.5*** 50.0  8.3yyy <0.000
BMI (kg/m2) 18.2  0.5*** 23.8  2.3yyy <0.000
BMI z-score 0.02  0.14*** 1.49  0.40yyy <0.000
Waist circumference
(cm)
62.4  3.7*** 77.6  6.2yyy <0.000
SBP (mmHg) 108.0  8.6 111.5  13.1 0.064
DBP (mmHg) 71.1  7.5 71.2  8.8 0.930
AST (U/L) 23.3  2.8** 26.3  9.1 0.008
ALT (U/L)b 13.8  3.9* 26.7  23.2 <0.000
Total cholesterol
(mg/dL)
167.1  24.5 173.8  27.9 0.159
HDL-C (mg/dL) 60.1  12.0 52.0  10.8 <0.000
TG (mg/dL)a,b 61.5  34.1 104.5  63.8 <0.000
Glucose (mg/dL) 86.3  6.4** 85.8  8.0yy 0.714
Insulin (mIU/mL)a,b 6.1  4.2*** 12.0  11.0yyy <0.000
HOMA-IRa,b 1.3  0.9*** 2.5  2.4yyy <0.000
Metabolic risk
score
1.59  1.25*** 1.19  2.23yyy <0.000
MetS (%) d 17.3 d
aTested by unpaired Student t test (p0, *, y) or one-way analysis of variance (AN
analysis. All values are presented as mean  standard deviation (SD). * Baseline
vs. follow-up in obese; yp< 0.05; yy p< 0.01; yyyp< 0.001. ALTZ alanine amin
DBP Z diastolic blood pressure; HDL-C Z high-density lipoprotein-cholester
IU Z international unit; SBP Z systolic blood pressure; TG Z triglyceride; Uand all had a significantly greater body weight, BMI,
BMI z-score, and waist circumference than did the
others. HOMA-IR values and levels of serum ALT, TG,
and insulin were significantly higher and HDL-C was
significantly lower in obese individuals (Table 1). Two
years later, the children were examined once more. Of
the 56 individuals who were not obese at baseline,
categorized as “lean”, 40 boys had BMI values below
the 60th percentile at follow-up. Of the 75 initially obese
boys, 57 remained obese at follow-up. At this time, 14
boys who were not obese at baseline and 20 boys who
were obese at that time had BMI values in the 60e85%
percentile, and were categorized as “intermediate” in
terms of obesity.
The baseline and follow-up data of lean and obese
individuals were compared. Not surprisingly, the mean
values of height, weight, BMI, and waist circumference
of both groups increased significantly over the 2 years,
as did blood glucose and insulin levels, and HOMA-IR
values. The mean values of BMI z-score, AST, and ALT
levels were lower in lean boys at follow-up than at
baseline, but this was not true of obese individuals. The
mean SBP, diastolic blood pressure (DBP), and lipid
levels (total cholesterol, HDL-C, and TG) did not differ
between baseline and follow-up in either group.
At follow-up, obese boys had a significantly greater
BMI z-score, and waist circumference than lean orstudy participants.a
Follow-up
Lean (n Z 40)
Intermediate
(n Z 34) Obese (n Z 57) p1
a
12.5  0.7 12.2  0.6 12.3  0.7 0.274
156.9  7.3 156.5  7.9 157.0  8.1 0.923
1 46.5  5.1 53.3  6.8 65.1  12.1 <0.0001
1 18.8  0.8 21.7  1.0 26.2  3.0 <0.0001
1 0.21  0.26 0.68  0.24 1.60  0.46 <0.0001
1 66.4  5.1 74.9  5.8 85.5  8.1 <0.0001
107.8  10.5 109.7  11.7 115.1  10.4 0.001
68.2  10.3 69.1  9.0 70.9  8.3 0.152
21.7  3.1 23.0  4.0 28.3  14.8 0.001
1 12.1  3.6 16.0  8.6 34.5  37.1 <0.0001
161.0  18.6 161.4  33.4 173.3  31.2 0.030
1 61.0  10.9 55.9  12.3 49.4  9.4 <0.0001
1 57.1  28.0 89.8  41.5 117.4  60.5 <0.0001
90.8  8.0 90.8  6.4 90.7  9.1 0.951
1 8.8  3.5 11.9  8.2 21.6  19.9 <0.0001
1 2.0  0.8 2.72  2.1 5.0  4.9 <0.0001
1 1.87  1.37 0.58  1.57 1.64  2.51 <0.0001
d 2.9 22.8 d
OVA; p1Z p value for linear trends); bData are log transformed prior to
vs. follow-up in control; *p < 0.05; **p < 0.01; ***p < 0.001. y Baseline
otransferase; ASTZ aspartate aminotransferase; BMIZ body mass index;
ol; HOMA-IR Z homeostasis model of assessment of insulin resistance;
Z unit.
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had significantly higher concentrations of ALT, TG, and
insulin and a higher mean HOMA-IR value than the
other groups.
3.2. Plasma PL fatty acid composition and
desaturase levels
Table 2 shows the relative proportions of 25 indi-
vidual fatty acids of plasma PLs. At baseline, over 63%
of total fatty acids were saturated (SFAs), and no sig-
nificant difference in the level of total SFA, palmitate,
or stearate was evident between obese and lean in-
dividuals. Monounsaturated fatty acids (MUFAs)
constituted 11% of total fatty acids in either group.
However, the palmitoleic acid (16:1n-7) level wasTable 2. Plasma PL fatty acid composition and estimated desa
Baseline
Control
(n Z 56)
Obese
(n Z 75) p0
Total SFA 63.5  5.8 63.4  7.5yy 0.776
c12:0 0.14  0.08 0.13  0.06 0.443
c14:0 0.54  0.14 0.51  0.11 0.385
c16:0 38.9  3.7 38.1  4.8 0.213
c18:0 21.2  2.3 21.7  2.8 0.341
c20:0 0.51  0.16 0.53  0.15 0.321
c22:0 1.17  0.49* 1.28  0.45 0.163
c24:0 1.05  0.41 1.10  0.38 0.371
Total MUFA 11.0  1.6 11.0  1.6y 0.889
c16:1n-7 0.43  0.18 0.51  0.20 0.018
c18:1n-9 6.89  1.46 6.79  1.55 0.589
c18:1n-7 1.25  0.23 1.16  0.21 0.039
c20:1n-9 0.32  0.26* 0.32  0.32 0.446
c22:1n-9 0.71  0.42 0.69  0.49 0.306
c24:1n-9 1.40  0.57 1.50  0.57 0.248
Total n-6 FA 21.7  4.3*** 21.8  5.7yyy 0.752
c18:2n-6 14.2  2.9 13.7  3.2 0.285
c18:3n-6 0.40  0.13 0.39  0.14 0.497
c20:2n-6 0.29  0.18 0.28  0.12 0.993
c20:3n-6 2.08  0.48 2.38  0.61 0.008
c20:4n-6 4.44  1.74* 4.74  2.30 0.891
c22:4n-6 0.18  0.09 0.21  0.09 0.108
Total n-3 FA 3.72  1.27 3.82  1.19yyy 0.632
c18:3n-3 0.11  0.07 0.13  0.07 0.109
c20:3n-3 1.15  0.70 0.96  0.63 0.319
c20:5n-3 0.37  0.33 0.42  0.30 0.340
c22:5n-3 0.58  0.34* 0.59  0.30yyy 0.709
c22:6n-3 1.51  1.03 1.71  1.14 0.453
Desaturase activity
D6D 0.15  0.04 0.18  0.04 <0.0001
D5D 2.15  0.78 1.95  0.80 0.075
SCD-16 0.011  0.005 0.013  0.006 0.016
SCD-18 0.334  0.100 0.323  0.099 0.462
aData are log transformed prior to analysis; bTested by unpaired Student t test (
trends).All values are presented as mean standard deviation (SD). * Baseline v
follow-up in obese; yp < 0.05; yyp < 0.01; yyyp < 0.001. D5D Z delta-5D; D
PL Z phospholipid; SCD Z stearyl-CoAD; SFA Z saturated fatty acid.higher in obese individuals. Although no difference in
total n-6 polyunsaturated fatty acid (PUFA) or 20:4n-6
level was observed, the DGLA (20:3n-6) level was
higher in obese individuals as were the SCD-16 and
D6D indices.
Baseline and follow-up data on lean and obese in-
dividuals were separately compared. The levels of only
four fatty acids (22:0, 20:1, 22:5n-3, and 20:4n-6)
differed between baseline and follow-up. The mean
22:5n-3 level increased in both groups at follow-up and
the mean 20:4 level fell in lean boys at follow-up. Obese
individuals had a higher palmitoleic acid and DGLA
level than lean boys at follow-up. Also, trends toward
increases in the SCD-16 and D6D indices were evident
in boys of heavier weight.turase activity of the study participants.a,b
Follow-up
Control
(n Z 33)
Intermediate
(n Z 25)
Obese
(n Z 46) p1
63.5  9.7 60.6  10.3 61.8  9.2 0.515
0.12  0.06 0.14  0.06 0.11  0.05 0.666
0.54  0.22 0.52  0.08 0.50  0.14 0.435
39.2  6.4 36.9  6.5 37.3  6.2 0.217
20.7  3.3 20.2  3.6 20.9  2.9 0.620
0.55  0.10 0.52  0.12 0.55  0.11 0.941
1.26  0.24 1.23  0.23 1.33  0.31 0.238
1.12  0.27 1.05  0.24 1.07  0.27 0.413
11.3  1.0 11.1  1.2 11.1  1.1 0.545
0.36  0.15 0.44  0.18 0.44  0.15 0.027
6.23  1.68 6.68  2.06 6.62  1.48 0.278
1.20  0.28 1.12  0.20 1.13  0.26 0.283
0.62  0.62 0.50  0.59 0.43  0.45 0.197
1.31  1.08 0.89  0.99 0.92  0.84 0.271
1.52  0.46 1.47  0.38 1.57  0.43 0.522
21.2  8.0 24.1  8.1 22.7  7.5 0.428
14.0  4.9 15.4  4.8 14.4  4.1 0.690
0.45  0.18 0.37  0.11 0.39  0.11 0.153
0.29  0.13 0.30  0.14 0.29  0.12 0.864
2.00  0.53 2.28  0.71 2.39  0.55 0.007
3.96  3.11 5.22  3.21 4.84  3.24 0.255
0.24  0.27 0.24  0.11 0.21  0.12 0.894
3.72  1.30 3.80  1.15 3.80  1.23 0.367
0.13  0.09 0.14  0.08 0.14  0.11 0.955
1.26  0.66 0.92  0.64 1.17  0.70 0.569
0.42  0.45 0.53  0.37 0.45  0.35 0.663
0.76  0.37 0.72  0.28 0.77  0.29 0.532
1.54  1.46 1.95  1.42 1.89  1.70 0.591
0.15  0.04 0.16  0.04 0.18  0.05 0.029
1.85  1.38 2.10  1.13 1.94  1.26 0.590
0.009  0.004 0.012  0.006 0.012  0.004 0.031
0.319  0.126 0.354  0.154 0.328  0.103 0.572
p0, *, y) or one-way analysis of variance (ANOVA; p1Z p value for linear
s. follow-up in control; *p< 0.05; **p< 0.01; ***p< 0.001. y Baseline vs.
6D Z delta-6D; FA Z fatty acid; MUFA Z monounsaturated fatty acid;
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desaturase levels and the risks of adiposity
and IR
The baseline level of palmitoleic acid (as a percent-
age of all fatty acids) was closely associated with WC
and metabolic risk score (r Z 0.217, p < 0.05;
r Z 0.221, p < 0.05, respectively). DGLA level was
also highly associated with WC, HDL-C, TG, and
metabolic risk score (rZ 0.205, p < 0.05; rZ 0.176,
p < 0.05; r Z 0.371, p < 0.001; r Z 0.260, p < 0.01,
respectively). The SCD-16 level was closely associated
with WC and metabolic risk score (rZ 0.209, p < 0.05;
r Z 0.200, p < 0.05, respectively) but not with the
HOMA-IR value (Table 3). The D6D level was highly
associated with most of the metabolic risk factors such
as WC, TG, and HDL-C. The D6D level was thus
positively associated with the HOMA-IR value and the
metabolic risk score (r Z 0.267, p < 0.01; r Z 0.394,
p < 0.001). The baseline D6D level showed significant
positive association with the follow-up WC, HOMA-IR,Table 3. Correlation coefficient between estimated desaturase a
D6D
Baseline
BMI (kg/m2) 0.414***
BMI z-score 0.410***
Waist circumference (cm) 0.414***
SBP (mmHg) 0.151
DBP (mmHg) 0.181*
AST 0.279**
ALT 0.370***
Total cholesterol (mg/dL) 0.214*
HDL-C (mg/dL) 0.292***
TG (mg/dL) 0.482***
Glucose (mg/dL) 0.138
Insulin (mIU/mL) 0.290**
HOMA-IR 0.267**
Metabolic risk score 0.394***
Follow-up
BMI (kg/m2) 0.445***
BMI z-score 0.456***
Waist circumference (cm) 0.480***
SBP (mmHg) 0.340***
DBP (mmHg) 0.203*
AST 0.131
ALT 0.306***
Total cholesterol (mg/dL) 0.197*
HDL-C (mg/dL) 0.289***
TG (mg/dL) 0.356***
Glucose (mg/dL) 0.004
Insulin (mIU/mL) 0.377***
HOMA-IR 0.364***
Metabolic risk score 0.436***
aTested by age-adjusted partial correlation analysis; data are log transformed
aminotransferase; AST Z aspartate aminotransferase; BMI Z body mass inde
HDL-C Z high-density lipoprotein-cholesterol; HOMA-IR Z homeostasis
SBP Z systolic blood pressure; SCD Z stearyl-CoAD; TG Z triglyceride.and metabolic risk score (r Z 0.480, r Z 0.364, and
r Z 0.436, respectively). The baseline D5D level
exhibited a negative association with them (Table 3).
A stepwise multiple regression analysis with the
baseline levels of age, BMI z-score, WC, TG, HDL-C,
and four estimated desaturase indices was performed
to investigate potential factors associated with the
follow-up HOMA-IR. Significant associations with the
follow-up HOMA-IR were found for baseline WC and
D6D (Table 4). Similarly, strong associations with the
follow-up metabolic risk score were found for baseline
WC and D6D level. Based on the regression analysis,
the baseline D6D level could be a major predictive
marker for future metabolic risks.4. Discussion
We investigated the relationships between individual
plasma PL fatty acids and desaturase activities andctivity and risks for metabolic syndrome.a
D5D SCD-16 SCD-18
0.203* 0.193* 0.093
0.209* 0.199* 0.097
0.254** 0.209* 0.137
0.137 0.153 0.068
0.160 0.031 0.039
0.124 0.153 0.013
0.164 0.155 0.070
0.030 0.073 0.110
0.082 0.090 0.055
0.144 0.166 0.015
0.219* 0.119 0.126
0.195* 0.036 0.072
0.161 0.050 0.054
0.258** 0.200* 0.006
0.279** 0.155 0.100
0.297*** 0.156 0.103
0.300*** 0.153 0.087
0.305*** 0.017 0.181*
0.155 0.092 0.061
0.145 0.012 0.092
0.258** 0.089 0.116
0.092 0.091 0.123
0.147 0.000 0.135
0.233** 0.090 0.105
0.219* 0.228** 0.208*
0.261** 0.046 0.066
0.278** 0.014 0.089
0.340*** 0.112 0.107
prior to analysis. *p < 0.05; **p < 0.01; ***p < 0.001. ALT Z alanine
x; D5D Z delta-5D; D6D Z delta-6D; DBP Z diastolic blood pressure;
model of assessment of insulin resistance; IU Z international unit;
Table 4. Stepwise multiple regression analysis for pre-
dicting follow-up HOMA-IR levels and meta-
bolic risk score.a,b
Variable
Adjusted
p r2b Coefficient
Follow up HOMA-IRc
Waist circumference 0.026 < 0.0001 0.206
D6D 0.619 0.007 0.250
Follow up metabolic risk scored
Waist circumference 0.135 <0.0001 0.356
D6D 2.338 0.002 0.402
aData are log transformed prior to analysis; bFor multiple stepwise
regression analysis, only the two independent variables incorporated into
the model are listed, and the r2 values displayed are cumulative; cIn-
dependent variables include: baseline age, BMI z-score, waist circum-
ference, TG, HDL-C, and desaturase; dIndependent variables include:
baseline age, waist circumference, and desaturase. BMI Z body mass
index; HDL-C Z high-density lipoprotein-cholesterol; HOMA-
IR Z homeostasis model of assessment of insulin resistance;
TG Z triglyceride.
256 Y.S. Choi, et almetabolic risk factors in Korean children. Furthermore,
we explored the longitudinal relations of estimates of
desaturase activity to body fatness, IR, and metabolic
risk score. Obese boys had significantly higher pro-
portions of palmitoleic acid and DGLA at baseline than
did lean children, in agreement with data on Japanese
children [9]. Increased DGLA levels are positively
associated with the development of metabolic disorders
in both adults and children [19e21]. A previous cross-
sectional study found that obese children have higher
proportions of DGLA in plasma lipids than do those of
normal weight [21]. Our data are in agreement with
these earlier reports. The present study, a longitudinal
study, also shows that obese boys had persistently high
proportions of DGLA and palmitoleic acid at follow-up.
Assessment of plasma DGLA level and/or palmitoleic
acid level would give useful information on obesity
status in children. Additionally, the present study shows
that the baseline plasma DGLA content was positively
associated with both present and future adiposity index
values and metabolic risk score in Korean children.
Plasma fatty acid composition could be regulated by
many factors such as dietary, hormonal, and environ-
mental factors [12,22]. To assess the effect of dietary
fatty acids on the serum PL fatty acid composition of the
study participant, a reliable database for fatty acid
composition of Korean food is needed, but was not
available at this time. Linoleic acid (18:2n-6) is directly
converted into 18:3n-6 by D6D and rapidly elongated to
20:3n-6 (DGLA) [22]. DGLA is converted into arach-
idonic acid by D5D [22]. The DGLA level, regulated by
D6D activity, is increased by insulin [12]. Hyper-
insulinemia induced by obesity might change the
expression level of D6D. We observed D6D had a
positive association with HOMA-IR, a surrogate marker
of IR for epidemiology study. The observed increases inDGLA concentration and D6D activity, accompanied by
a fall in D5D expression, in obese individuals suggest
that impaired fatty acid metabolism, possibly caused by
the development of IR, may trigger the accumulation of
DGLA. Although DGLA plays multiple roles in pro-
tecting against inflammation and cell proliferation [22],
increases in DGLA and D6D levels in association with
IR could nonetheless aggravate metabolic disorders. A
recent cross-sectional study with Korean adults sug-
gested D6D as a major factor for determining plasma
level of C-reactive protein, a surrogate marker for
inflammation [23].
Not only was the baseline D6D activity significantly
higher in obese than in lean children at baseline, but it
was also positively associated with adiposity indices at
follow-up. Baseline D6D activity also exhibited positive
associations with the follow-up values of surrogate
markers of IR and metabolic disorders, including the TG
level, HOMA-IR value, and metabolic risk score.
Accumulating evidence suggests that D6D plays a
crucial role in the development of obesity and metabolic
syndrome. High levels of D6D activity have been esti-
mated in adults with obesity, diabetes, and metabolic
syndrome [18,24,25]. Warensjo et al [25] found that a
higher estimated D6D activity increased the risk of
metabolic syndrome over 20 years in middle-aged men.
To the best of our knowledge, only one prior study [26]
explored the associations between longitudinal changes
in fatty acid composition and body fatness in children.
In that study, increased D6D activity was significantly
associated with an elevated waist-to-hip ratio in both
boys and girls. The authors suggested that D6D activity
was positively associated with an increased HOMA-IR
value only in girls [26]. However, their small sample
size may have limited the observations that could be
made. In the present study, the D6D levels did not vary
greatly over the 2 years, whereas the HOMA-IR level
increased. Thus, no positive association between
changes in D6D and changes in the HOMA-IR value
were noted. However, baseline D6D activity was posi-
tively associated with both baseline and follow-up
HOMA-IR values, and also follow-up metabolic risk
score. Results from the present multiple regression
analysis suggested that WC and D6D were the major
determinants of HOMA-IR and metabolic risk score, a
suggested tool for an early-life determination of meta-
bolic risk. Thus early detection of elevated D6D activity
in Korean boys may predict the future development of
IR and associated metabolic disorders including dysli-
pidemia. Adequate regulation of D6D level at an early
age may help prevent the development of metabolic
disorders.Conflicts of interest
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